SafeStart Vascular Access Start Kit
by Becton Dickinson Vascular Access, Inc.
510(k) K943941
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK943941 | Date20 Oct 1994 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LRS
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5200
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The SafeStart Vascular Access Start Kit is an Intravenous (I.V.) Start Kit, designed for initiating peripheral intravenous access. It combines components to facilitate safe and efficient insertion of catheters into veins, reducing the risk of complications such as infiltration or phlebitis during the procedure.
This kit is intended for single-use in clinical settings such as general hospitals. It is supplied sterile and includes various catheter sizes and accessories for compatibility with different patient needs. The device holds an FDA 510(k) clearance under the classification of Class II medical devices, adhering to regulatory standards for vascular access products.
Other devices from Becton Dickinson Vascular Access, Inc.
See all devices from Becton Dickinson Vascular Access, Inc. →
Questions
AI-generated answers, 19 Sep 2026
What types of clinical settings is the SafeStart Vascular Access Start Kit designed for, and why is this important for me as a clinician?
The SafeStart Vascular Access Start Kit is specifically designed for use in general hospitals, as indicated by its regulatory filing under the 'General Hospital' advisory committee description. This means it is optimized for standard inpatient care where peripheral intravenous access is commonly required. As a clinician, this ensures the kit aligns with typical hospital workflows and patient needs, reducing the risk of complications like infiltration or phlebitis during catheter insertion.
Is the SafeStart Vascular Access Start Kit reusable, or is it meant for single-use only? How does this affect its sterility?
The SafeStart Vascular Access Start Kit is intended for single-use only, as explicitly stated in the description. This design ensures sterility is maintained throughout its intended use, minimizing infection risks. Single-use kits also eliminate the need for reprocessing, which can be time-consuming and may introduce contamination if not done properly.
What catheter sizes are included in the SafeStart Vascular Access Start Kit, and how do I know which one to choose for a patient?
While the exact catheter sizes aren’t listed in the provided data, the kit includes various catheter sizes to accommodate different patient needs, such as veins of varying sizes or age groups (e.g., pediatric to adult). The kit’s design emphasizes compatibility with diverse patient populations, so you would select the appropriate size based on clinical assessment—typically matching the vein’s diameter and patient’s age/condition—for optimal insertion and flow rates.
How should I store the SafeStart Vascular Access Start Kit to ensure it remains effective and sterile until use?
Since the kit is sterile and intended for single-use, it should be stored in its original, unopened packaging in a clean, dry environment away from direct sunlight or extreme temperatures. Check the packaging for any specific storage instructions (e.g., refrigeration if applicable), but generally, room-temperature storage is standard for sterile, single-use medical devices like this. Always verify the expiration date before use to ensure sterility and functionality.
What regulatory pathway does the SafeStart Vascular Access Start Kit follow, and what does this mean for its safety and reliability?
The kit holds an FDA 510(k) clearance under the classification of Class II medical devices, meaning it has undergone rigorous review to demonstrate substantial equivalence to a legally marketed predicate device. This pathway ensures the product meets established safety and performance standards for vascular access kits, giving clinicians confidence in its reliability for reducing complications like infiltration or phlebitis during peripheral IV insertion.